GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Ocean Bio-Chem Inc (NAS:OBCI) » Definitions » Cash Flow from Operations

Ocean Bio-Chem (Ocean Bio-Chem) Cash Flow from Operations : $-0.21 Mil (TTM As of Jun. 2022)


View and export this data going back to 1978. Start your Free Trial

What is Ocean Bio-Chem Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Jun. 2022, Ocean Bio-Chem's Net Income From Continuing Operations was $-0.32 Mil. Its Depreciation, Depletion and Amortization was $0.46 Mil. Its Change In Working Capital was $-5.10 Mil. Its cash flow from deferred tax was $0.00 Mil. Its Cash from Discontinued Operating Activities was $0.00 Mil. Its Asset Impairment Charge was $0.00 Mil. Its Stock Based Compensation was $0.00 Mil. And its Cash Flow from Others was $-0.04 Mil. In all, Ocean Bio-Chem's Cash Flow from Operations for the three months ended in Jun. 2022 was $-4.99 Mil.


Ocean Bio-Chem Cash Flow from Operations Historical Data

The historical data trend for Ocean Bio-Chem's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocean Bio-Chem Cash Flow from Operations Chart

Ocean Bio-Chem Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.93 1.22 5.99 6.21 5.51

Ocean Bio-Chem Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.73 -0.07 5.09 -0.24 -4.99

Ocean Bio-Chem Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Ocean Bio-Chem's Cash Flow from Operations for the fiscal year that ended in Dec. 2021 is calculated as:

Ocean Bio-Chem's Cash Flow from Operations for the quarter that ended in Jun. 2022 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ocean Bio-Chem  (NAS:OBCI) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Ocean Bio-Chem's net income from continuing operations for the three months ended in Jun. 2022 was $-0.32 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Ocean Bio-Chem's depreciation, depletion and amortization for the three months ended in Jun. 2022 was $0.46 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Ocean Bio-Chem's change in working capital for the three months ended in Jun. 2022 was $-5.10 Mil. It means Ocean Bio-Chem's working capital declined by $5.10 Mil from Mar. 2022 to Jun. 2022 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Ocean Bio-Chem's cash flow from deferred tax for the three months ended in Jun. 2022 was $0.00 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Ocean Bio-Chem's cash from discontinued operating Activities for the three months ended in Jun. 2022 was $0.00 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Ocean Bio-Chem's asset impairment charge for the three months ended in Jun. 2022 was $0.00 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Ocean Bio-Chem's stock based compensation for the three months ended in Jun. 2022 was $0.00 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Ocean Bio-Chem's cash flow from others for the three months ended in Jun. 2022 was $-0.04 Mil.


Ocean Bio-Chem Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Ocean Bio-Chem's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Ocean Bio-Chem (Ocean Bio-Chem) Business Description

Traded in Other Exchanges
N/A
Address
4041 SW 47 Avenue, Fort Lauderdale, FL, USA, 33314
Ocean Bio-Chem Inc is engaged in the manufacturing, marketing, and distribution of a broad line of appearance, performance and maintenance products for the marine, automotive, power sports, recreational vehicle, home care and outdoor power equipment markets, under the Star brite and Star Tron brand names. It sells these products within the USA and Canada. The company produces private label formulations of many of its products for various customers and provide custom blending and packaging services for these and other products. It also manufactures, markets and distributes chlorine dioxide-based deodorizing disinfectant, and sanitizing products under the Star brite and Performacide brand names, utilizing a patented delivery system for use with products containing chlorine dioxide.
Executives
Peter G Dorau director, officer: President-CEO 1601 SE 10 STREET FORT LAUDERDALE FL 3316
Gregor M Dornau officer: Vice President 1305 MANDARIN ISLE FORT LAUDERDALE FL 33315
William Dudman officer: Vice President - Operations 6040 SW 15 STREET PLANTATION FL 33317
John B Turner director 16101 SW 156 AVENUE MIAMI FL 33186
Jeffrey Barocas director, officer: Chief FInancial Officer 4041 SW 47TH AVE, FT LAUDERDALE FL 33314
Diana Conard director 4041 SW 47TH AVE FORT LAUDERDALE FL 33314
Kim Krause director 4041 SW 47TH AVENUE FORT LAUDERDALE FL 33314
James M Kolisch director
Peter Dornau Family, Llc other: Trust 4041 SW 47TH AVE FT. LAUDERDALE FL 33314
Edward Anchel director, officer: Vice President-CFO 7566 VIA GRANDE BOYNTON BEACH FL 33437
Anca Vague other: Controller - Financial Reptg. 1505 N RIVERSIDE DRIVE APT.302 POMPANO BEACH FL 33062
Lindsey George W Jr officer: Vice President 1833 WASHINGTON STREET HOLLYWOOD FL 33319
Sonia B Beard director 1708 SHORE DR MERRITT ISLAND FL 32952
Laz L Schneider director 2525 NE 26 TERRACE FORT LAUDERDALE FL 33305
Jeffrey Tieger director, officer: Vice President 10180 SW 4 STREET PLANTATION FL 33314

Ocean Bio-Chem (Ocean Bio-Chem) Headlines

From GuruFocus

PERFORMACIDE� Kills Virus Causing COVID-19 In Just 30 Seconds

By PRNewswire PRNewswire 06-22-2021